Company intelligence / Profile preview

OvaScience

Cambridge, Massachusetts, United Statesovascience.com ↗
Ownership
Private
Employees
~50
Development stage
Other
01

Overview

OvaScience developed proprietary fertility treatments based on the discovery of EggPC cells—immature egg precursor cells found in adult ovaries. Its lead service "Augment" involved mitochondrial transfer from these precursor cells into a woman's own eggs during IVF to improve fertilization and pregnancy rates. Another program "OvaTure" aimed to mature new eggs from these precursor cells entirely outside the body. The company’s claims were controversial and not approved for use in the United States; Augment was available only through select clinics abroad before operations ceased following a reverse merger with Millendo Therapeutics in 2018.

Therapeutic areas
Women's Health
Modalities
Cell-based therapies (EggPC cells)Mitochondrial augmentationIn vitro maturation of oocytes
Industry
Biotech
02

Partnerships

Exclusive license agreement with IVF Japan for AUGMENT treatment delivery in Japan

Beyond the preview

Go deeper on OvaScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OvaScience.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call